CLINICAL_TRIALS
trial_result
· 2011-01-26
Clinical Trial Update: Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 trial assessed adding exenatide to insulin glargine in people with type 2 diabetes, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2011-01-26